menu
    • menu

    Company profile for CuraTeQ Biologics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma Ltd., is an EU GMP certified biopharmaceutical company based in Hyderabad, India. The company focuses on developing and manufacturing biosimilars and vaccines, with a leadership team comprising scientific experts in the field. CuraTeQ is committed to creating a sustainable and broad portfolio of biosimilars, particularly in oncology and immunology, aiming to prov...
    CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma Ltd., is an EU GMP certified biopharmaceutical company based in Hyderabad, India. The company focuses on developing and manufacturing biosimilars and vaccines, with a leadership team comprising scientific experts in the field. CuraTeQ is committed to creating a sustainable and broad portfolio of biosimilars, particularly in oncology and immunology, aiming to provide affordable and effective treatments for a range of serious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CuraTeQ Biologicsindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Galaxy Towers, Floors: 22-24, Plot No. 1, Survey No. 83/1, Hyderabad Knowled...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://curateqbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CuraTeQ Bio Completes Ph 3 Study for Denosumab Biosimilar
    CuraTeQ Bio Completes Ph 3 Study for Denosumab Biosimilar

    19 Sep 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/curateq-biologics-completes-phase-3-clinical-study-for-denosumab-biosimilar-17842

    INDPHARMAPOST
    19 Sep 2025
    Share Share
    Aurobindo's Unit Receive UK Approval for Biosimilar Breast Cancer
    Aurobindo's Unit Receive UK Approval for Biosimilar Breast Cancer

    27 Aug 2025

    // BUSINESS STD

    https://www.business-standard.com/industry/news/aurobindo-pharma-subsidiary-uk-approval-breast-cancer-drug-dazublys-125082601330_1.html

    BUSINESS STD
    27 Aug 2025
    Share Share
    CuraTeQ Biologics`s Dazublys Receives Approval in Europe
    CuraTeQ Biologics`s Dazublys Receives Approval in Europe

    30 Jun 2025

    // EMA

    https://www.ema.europa.eu/en/documents/overview/dazublys-epar-medicine-overview_en.pdf

    EMA
    30 Jun 2025
    Share Share
    Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA
    Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA

    14 May 2025

    // THEHINDU

    https://www.thehindu.com/business/aurobindo-pharma-arms-biosimilar-gets-marketing-nod-from-uks-mhra/article69572375.ece

    THEHINDU
    14 May 2025
    Share Share
    CuraTeQ Biologics gets positive opinion for Dazublys biosimilar
    CuraTeQ Biologics gets positive opinion for Dazublys biosimilar

    28 Apr 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/curateq-biologics-receives-positive-opinion-for-biosimilar-dazublys-from-ema-17080

    INDPHARMAPOST
    28 Apr 2025
    Share Share
    CuraTeQ Biologics finishes Phase 1 study of Denosumab biosimilar
    CuraTeQ Biologics finishes Phase 1 study of Denosumab biosimilar

    09 Apr 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/curateq-biologics-completes-phase-1-pharmacokinetics-study-of-biosimilar-denosumab-17000

    INDPHARMAPOST
    09 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search